TRIALYS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
TRIALYS
Largest movements
- Cash +€890,720
up €890,720 (+1534.6%), from €58,041 to €948,761
mainly Other debts (+€924,655) and Receivables within one year (+€35,880)
- Receivables within one year -€35,880
down €35,880 (-69.3%), from €51,798 to €15,918
of which Trade receivables: -€25,385
- Other debts +€924,655
new in 2025: €924,655
- Trade debts -€70,520
down €70,520 (-74.1%), from €95,120 to €24,600
- Gross operating margin +€8,293
up €8,293, from -€824 to €7,469
- Write-downs +€6,149
new in 2025: €6,149
- Depreciation -€893
no longer reported in 2025 (was €893)
- Other operating charges -€296
down €296 (-42.5%), from €696 to €400
- Financial income -€164
down €164 (-99.4%), from €165 to €1
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €110,852 | €965,755 | +€854,903 | +771.2% |
| Current assets | 29/58 | €110,852 | €965,755 | +€854,903 | +771.2% |
| Amounts receivable within one year | 40/41 | €51,798 | €15,918 | -€35,880 | -69.3% |
| Trade receivables | 40 | €41,303 | €15,918 | -€25,385 | -61.5% |
| Other amounts receivable | 41 | €10,495 | - | -€10,495 | |
| Cash at bank and in hand | 54/58 | €58,041 | €948,761 | +€890,720 | +1534.6% |
| Deferred charges and accrued income | 490/1 | €1,013 | €1,076 | +€63 | +6.2% |
| Total equity and liabilities | 10/49 | €110,852 | €965,755 | +€854,903 | +771.2% |
| Equity | 10/15 | €15,732 | €16,377 | +€645 | +4.1% |
| Contributions | 10/11 | €8,060 | €8,060 | = | 0.0% |
| Profit (loss) carried forward | 14 | €7,672 | €8,317 | +€645 | +8.4% |
| Amounts payable | 17/49 | €95,120 | €949,378 | +€854,258 | +898.1% |
| Amounts payable within one year | 42/48 | €95,120 | €949,378 | +€854,258 | +898.1% |
| Trade debts | 44 | €95,120 | €24,600 | -€70,520 | -74.1% |
| Suppliers | 440/4 | €95,120 | €24,600 | -€70,520 | -74.1% |
| Taxes, remuneration and social security | 45 | - | €123 | +€123 | |
| Taxes | 450/3 | - | €123 | +€123 | |
| Other amounts payable | 47/48 | - | €924,655 | +€924,655 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €893 | - | -€893 | |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €6,149 | +€6,149 | |
| Other operating charges | 640/8 | €696 | €400 | -€296 | -42.5% |
| Gross operating margin | 9900 | -€824 | €7,469 | +€8,293 | |
| Operating profit (loss) | 9901 | -€2,413 | €920 | +€3,333 | |
| Financial income | 75/76B | €165 | €1 | -€164 | -99.4% |
| Recurring financial income | 75 | €165 | €1 | -€164 | -99.4% |
| Financial charges | 65/66B | €308 | €276 | -€32 | -10.4% |
| Recurring financial charges | 65 | €308 | €276 | -€32 | -10.4% |
| Profit (loss) for the period before taxes | 9903 | -€2,556 | €645 | +€3,201 | |
| Profit (loss) for the period | 9904 | -€2,556 | €645 | +€3,201 | |
| Profit (loss) for the period to be appropriated | 9905 | -€2,556 | €645 | +€3,201 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.